Today’s guest post comes from Mark Bouck, President and CEO of TrialCard.
Mark reviews copay accumulator adjustment programs and shares some of TrialCard’s unique data about these programs. He also discusses TrialCard’s proprietary methodology for identifying patients affected by this benefit design. This topic is crucial for 2018 (per my own article from January), so I encourage you to review his commentary.
To learn more about TrialCard’s approach to copay accumulator programs, download the free e-book The Rise of Co-Pay Accumulator Programs: Are Your Brand’s Patients at Risk?
To learn more about TrialCard’s solutions for accumulators, email Mark Droke, TrialCard's Senior Vice President, Patient Affordability & Virtual Engagement Business Units, at mark.droke@trialcard.com. You can visit Trialcard in booth 610 at Asembia’s upcoming 2018 Specialty Pharmacy Summit.
Read more »
Source: Post feed
